This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Shandong University, Tsingtao A-Smart Medical Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Keliang Wu: Innovator in Ovarian Treatment Technologies
Introduction
Keliang Wu is a notable inventor based in Shandong, China. He has made significant contributions to the field of reproductive health through his innovative methods and technologies. His work focuses on enhancing the developmental and reproductive potential of mammalian ovaries.
Latest Patents
Keliang Wu holds a patent for a method titled "Method for activating follicles by means of using small-molecule compound." This patent discloses a method and culture medium for performing in vivo treatment on ovaries of mammals, including humans, or for conducting in vitro culturing on ex vivo ovaries or ovarian tissue using 4-vinylcyclohexene diepoxide. The method provided facilitates the retention and enhancement of the developmental and reproductive potential of mammalian ovaries or ovarian tissue. It is particularly effective in promoting follicle maturation and increasing the number of ovulations. He has 1 patent to his name.
Career Highlights
Throughout his career, Keliang Wu has worked with various organizations that focus on medical technology and research. Notably, he has been associated with Tsingtao A-Smart Medical Technology Co., Ltd. and Shandong University. His work in these institutions has allowed him to advance his research and contribute to the field of reproductive health.
Collaborations
Keliang Wu has collaborated with several professionals in his field, including Gang Lu and Jinlong Ma. These collaborations have enriched his research and have led to advancements in the methodologies he has developed.
Conclusion
Keliang Wu is a prominent inventor whose work in ovarian treatment technologies has the potential to significantly impact reproductive health. His innovative methods and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile